Fibroblast growth factor 21-inducing rare sugars prevent diet-induced obesity in male BL/6 mice
Open Access
- 1 January 2026
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 73 (6) , 677-690
Abstract
The consumption of a high-fat, high-sucrose diet (HFHSD) promotes obesity. Although dietary sugars are obesogenic, they activates a negative feedback mechanism between hepatic fibroblast growth factor 21 (FGF21) and oxytocin neurons in the paraventricular nucleus of the hypothalamus (PVHOxt), thereby suppressing sugar appetite. We previously reported that the low-calorie rare sugars d-allulose, d-tagatose, and d-sorbitol induce FGF21, activate PVHOxt neurons, and reduce sugar intake. In this study, we evaluated the anti-obesity effects of these rare sugars in male BL/6 mice. The mice were fed with HFHSD, along with ad libitum access to FGF21-inducing rare sugar solutions for 1 month. Body weight, feed intake, fluid intake, and total caloric intake were recorded every 3 days. At the end of the treatment, obesity-associated parameters—including insulin resistance, glucose intolerance, and adiposity—were assessed. Rare sugar supplementation reduced body weight gain and total caloric intake without increasing energy expenditure. These interventions improved obesity-associated phenotypes to varying degrees, suggesting that these rare sugars ameliorated the overall state of diet-induced obesity. In contrast, these sugars did not reverse established obesity or insulin resistance, as prolonged HFHSD feeding desensitized mice to their effects. Therefore, rare sugars appear effective for the prevention, but not the treatment, of diet-induced obesity.Keywords
Funding Information
- Japan Society for the Promotion of Science (20H00412)
- Kyoto University
- Japan Foundation for Applied Enzymology
- Naito Foundation
- Kao Health Science Foundation
- Sumitomo Foundation
- MSD Life Science Foundation, Public Interest Incorporated Foundation
- Uehara Memorial Foundation
- Japan Food Chemical Research Foundation
- Kyoto University Foundation
This publication has 37 references indexed in Scilit:
- Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatmentObesity, 2023
- Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019eClinicalMedicine, 2023
- Acute responses of stevia and d-tagatose intake on metabolic parameters and appetite/satiety in insulin resistanceClinical Nutrition ESPEN, 2022
- Effect of fructose and its epimers on postprandial carbohydrate metabolism: A systematic review and meta-analysisClinical Nutrition, 2020
- Temporal sweetness and side tastes profiles of 16 sweeteners using temporal check-all-that-apply (TCATA)Food Research International, 2019
- Rare sugars, d‐allulose, d‐tagatose and d‐sorbose, differently modulate lipid metabolism in ratsJournal of the Science of Food and Agriculture, 2017
- Defining the Nutritional and Metabolic Context of FGF21 Using the Geometric FrameworkCell Metabolism, 2016
- FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight LossCell Metabolism, 2014
- Hypothalamic SIRT1 prevents age-associated weight gain by improving leptin sensitivity in miceDiabetologia, 2013
- Disposition of-[U-14C]Tagatose in the RatRegulatory Toxicology and Pharmacology, 1999